Skip to main content
Loading ResearchHub…
References for Lipocalin 13 Mitigates Metabolic Dysfunction‐Associated Steatotic Liver Disease Through Inhibiting the ADRB2 / ERK Signalling Pathway | ResearchHub - ResearchHub